Connect Biopharma Holdings Limited · NASDAQ:CNTB
Xanthopoulos Kleanthis Gabriel received 5,000 Connect Biopharma Holdings Limited shares as an award (Form 4)
Traded Sep 30, 2026 · Filed Oct 1, 2026
On Sep 30, 2026, Xanthopoulos Kleanthis Gabriel (Director) received 5,000 Connect Biopharma Holdings Limited shares as an award, leaving 91,554 shares. Filed Oct 1, 2026 (Form 4).
- Awarded
- 5,000 shares
- Holding after
- 91,554 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Ordinary Shares | Award | 5,000 | 91,554 | Direct |
Source
Related
- Connect Biopharma Holdings Limited
- Xanthopoulos Kleanthis Gabriel
- Connect Biopharma Holdings Limited shareholders
- Form 4 · Xanthopoulos Kleanthis Gabriel · Jul 1, 2026
- Form 4 · Xanthopoulos Kleanthis Gabriel · Apr 2, 2026
- Schedule 13G · Braden M Leonard · Oct 6, 2026
- Form 4 · Liu Jean I · Oct 1, 2026
- Form 4 · Liu Jean I · Jul 1, 2026
- Form 4 · Huang James · Jun 2, 2026
- Form 4 · Liu Jean I · Apr 2, 2026